|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.330 CNY | -1.77% |
|
-2.06% | -16.33% |
| Market Cap | 2.61B 386M 338M 313M 287M 542M 37.2B 551M 3.74B 1.46B 18.2B 1.45B 1.42B 62.7B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.83B 418M 366M 338M 311M 587M 40.29B 597M 4.05B 1.59B 19.71B 1.57B 1.53B 67.92B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.77% | ||
| 1 week | -2.06% | ||
| Current month | +12.12% | ||
| 1 month | +7.07% | ||
| 3 months | -27.29% | ||
| 6 months | -19.76% | ||
| Current year | -16.33% |
| 1 week | 3.28 |  | 3.64 |
| 1 month | 2.85 | | 3.64 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.77% | -2.06% | -21.28% | -35.09% | 392M | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,051B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 609B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 450B | |
| -0.75% | +0.30% | +28.32% | +21.15% | 330B | |
| -1.52% | -1.19% | +33.38% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.26% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.89% | -40.59% | 223B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 198B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 167B | |
| Average | -0.86% | -0.55% | +22.09% | +39.26% | 357.55B | |
| Weighted average by Cap. | -0.89% | -1.07% | +35.24% | +70.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 321M 281M 260M 239M 451M 30.96B 459M 3.11B 1.22B 15.15B 1.21B 1.18B 52.19B | 1.86B 275M 241M 223M 205M 387M 26.53B 393M 2.67B 1.04B 12.98B 1.03B 1.01B 44.72B |
| Net income | -317M -46.84M -41.06M -37.95M -34.91M -65.86M -4.52B -66.92M -454M -178M -2.21B -176M -172M -7.62B | -330M -48.67M -42.66M -39.43M -36.26M -68.42M -4.69B -69.52M -471M -185M -2.3B -183M -179M -7.91B |
| Net Debt | 411M 60.68M 53.18M 49.16M 45.21M 85.31M 5.85B 86.68M 588M 230M 2.86B 228M 223M 9.86B | 217M 32.06M 28.1M 25.98M 23.89M 45.08M 3.09B 45.8M 311M 122M 1.51B 120M 118M 5.21B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | CN¥3.330 | -1.77% | 28,104,500 |
| 26-07-17 | CN¥3.390 | -6.09% | 34,476,780 |
| 26-07-16 | CN¥3.610 | +3.44% | 42,692,849 |
| 26-07-15 | CN¥3.490 | +0.58% | 37,168,652 |
| 26-07-14 | CN¥3.470 | +2.06% | 30,082,403 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
